Krsnaa Diagnostics Ltd (NSE: KRSNAA, BSE: 543328) is a Pune, Maharashtra-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹1,625 Cr, it ranks #1,345 by market cap among the 6,197 Indian listed companies on FinBizNet, and #6 of 18 in Medical Diagnostic Centres. At ₹530.00 (as of 16 Nov 2026), the share price is 36.8% below its 52-week high of ₹838.00 and 14.4% above its 52-week low of ₹463.10. The share price is down 27.0% over one year and down 5.0% over three months.
| Current Price | ₹530.00 |
|---|---|
| Market Cap | ₹1,625 Cr |
| NSE Symbol | KRSNAA |
| BSE Code | 543328 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 16.8 |
| Return on Equity | 10.89% |
| Return on Assets | 4.89% |
| 52-Week Range | ₹463.10 – ₹838.00 |
| 1-Year Price Change | -27.0% |
| 3-Month Price Change | -5.0% |
| Beta (1Y) | 0.37 |
| Dividend Yield | 0.39% |
| Headquarters | Pune, Maharashtra |
| Website | krsnaadiagnostics.com |
| Revenue | ₹271 Cr |
|---|---|
| Net Profit | ₹25 Cr |
| Net Margin | 9.1% |
| EPS (Basic) | ₹7.64 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Krsnaa Diagnostics Ltd reported revenue of ₹271 Cr in Q2 FY27, up 31.5% from ₹206 Cr in Q2 FY26 and up 15.0% from ₹236 Cr in Q1 FY27. It posted a net profit of ₹25 Cr for the quarter, against a net profit of ₹24 Cr in Q2 FY26 (up 2.7%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹181 Cr (Q3 FY26) to ₹271 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹271 Cr | ₹25 Cr | 9.1% |
| Q1 FY27 | ₹236 Cr | ₹17 Cr | 7.0% |
| Q4 FY26 | ₹193 Cr | ₹42 Cr | 21.7% |
| Q3 FY26 | ₹181 Cr | ₹15 Cr | 8.4% |
| Q2 FY26 | ₹206 Cr | ₹24 Cr | 11.6% |
| Q1 FY26 | ₹193 Cr | ₹21 Cr | 10.6% |
| Q4 FY25 | ₹186 Cr | ₹21 Cr | 11.1% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 27.11% of Krsnaa Diagnostics Ltd's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 52.7% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves individual patients, government clients, corporate clients, hospitals, clinics, private practitioner, and other healthcare providers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.
1. Radiology and Pathology Services-This segment provides diagnostic services. It offers radiology and pathology services for X-ray, CT-scan, MRI, mammography, tele-reporting, and various types of blood and urine investigations.
1. Diagnostic Services in Radiology and Pathology Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Dr. Lal Pathlabs Ltd | ₹33,934 Cr | 66.4 | 21.48% | ₹874 Cr | +28.7% |
| Vijaya Diagnostic Centre Limited | ₹14,665 Cr | 84.3 | 19.70% | ₹255 Cr | +38.5% |
| Metropolis Healthcare Limited | ₹11,952 Cr | 61.5 | 13.37% | ₹497 Cr | +14.9% |
| Throcare Technologies Ltd | ₹7,764 Cr | 47.6 | 28.74% | ₹271 Cr | +7.5% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,856 Cr | 55.4 | 13.84% | ₹99 Cr | +6.9% |
| Krsnaa Diagnostics Ltd | ₹1,625 Cr | 16.8 | 10.89% | ₹271 Cr | -27.0% |
| Gaudium IVF and Women Health Limited | ₹803 Cr | 27.4 | 16.08% | ₹37 Cr | — |
| Chandan Healthcare Limited | ₹582 Cr | 21.9 | 18.43% | ₹81 Cr | — |
| Aspira Pathlab & Diagnostics Ltd | ₹127 Cr | 2,360 | — | — | +115.2% |
Listed by market capitalisation. Ratios are shown for context only.
Krsnaa Diagnostics Ltd is trading at ₹530.00, with a market capitalisation of ₹1,625 Cr.
Krsnaa Diagnostics Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Krsnaa Diagnostics Ltd has a P/E of 16.8 and a return on equity of 10.89%.
Krsnaa Diagnostics Ltd is listed on the NSE under the symbol KRSNAA and on the BSE under the scrip code 543328.
Krsnaa Diagnostics Ltd's share price is down 27.0% over one year and down 5.0% over three months. Its 52-week range is ₹463.10 to ₹838.00.
In Q2 FY27, Krsnaa Diagnostics Ltd reported revenue of ₹271 Cr and net profit of ₹25 Cr, with basic EPS of ₹7.64 (consolidated, parsed from the company's exchange filing).
Krsnaa Diagnostics Ltd reported revenue of ₹271 Cr in Q2 FY27, up 31.5% from ₹206 Cr in Q2 FY26 and up 15.0% from ₹236 Cr in Q1 FY27.
Promoters held 27.11% of Krsnaa Diagnostics Ltd's shares as of Sept 2026, unchanged from Sept 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.